Evaluation of Pharmacist Intervention for Individuals With Uncontrolled Type 2 Diabetes (NCT05442840)
Evaluation of Pharmacist Intervention and Education in a Patient-Centered, Multidisciplinary Approach for Individuals With Uncontrolled Type 2 Diabetes
🩺 Plain-English Summary (8th-Grade Level)
Type 2 diabetes is a chronic disease that can lead to a number of complications if uncontrolled and there is a projected increase of 33% patients living with diabetes over the next 10 years. There can be improvements to modifiable risk factors such as diet and exercise, in addition to medications. Treatment often involves a multidisciplinary approach with a physician, endocrinologist, dietitian, pharmacist and other support health professionals as required. This study will evaluate the effects of the pharmacists (or pharmD interns) intervention, looking at changes to the patients HbA1C, which is a measure of the patients blood glucose control over the previous 3 months as well as the patients understanding and comfort with managing their own diabetes via participant survey.
Who can join: Review the eligibility criteria below.
Location: Portage Clinic — Portage la Prairie, Manitoba
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Portage Clinic — Portage la Prairie, Manitoba
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Diabetes Type 2
- Deploying Digital Prosthetic Interface Technology and Exercise in Dysvascular Amputees — Boston, Massachusetts
- Enhancing Diabetes Care by Treating Insomnia — Zachary, Louisiana
- Canagliflozin Targeting Vascular Inflammation — Ottawa, Ontario
- Metformin Effects According to SLC16A11 Carrier Status — Mexico City, Mexico City
- Effect of the Thrive AI Health App on Lifestyle Behaviors and Quality of Life — New Haven, Connecticut
Explore by condition: All Diabetes Type 2 clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.